The levels of biomarkers like Lp-PLA2 activity and hsCRP were elevated among the subjects with metabolic syndrome and without atherosclerotic diseases.

Metabolic syndrome (MS) is a group of cardiovascular risk factors associated with increased levels of inflammatory markers. A comparison of levels of inflammatory markers of metabolic syndrome (Lp-PLA2 and hsCRP) was evaluated and reported.

Both high sensitivity C-reactive protein (hsCRP) and lipoprotein-associated phospholipase A2 (Lp-PLA2) are the predictors of MS and deemed to be independent of each other.

Findings: high sensitivity C-reactive protein (hsCRP)

  • Mean hsCRP levels were 2.1 +/-2.2 mg/L
  • Gender of the subject did not show significant difference in their mean hsCRP levels
  • Had a significant and direct correlation with BMI, waist circumference, blood glucose, systolic BP, non-HDL-C, and fibrinogen
  • Had significant and inverse correlation with HDL-C

Findings: Lipoprotein-associated phospholipase A2 (Lp-PLA2)(hsCRP)

  • Mean Lp-PLA2 activity level were 185 ± 48 nmol/mL/min
  • Men and women showed a significant difference in their Lp-PLA2 levels (men: 201 nmol/mL/min and women: 166 nmol/mL/min)
  • Had significant and direct correlation with BMI, waist circumference, diastolic BP, LDL-C, non-HDL-C, and plasma creatinine
  • Had a significant and inverse correlation with HDL-C
  • Had no significant correlations with blood glucose, systolic BP, hsCRP, and fibrinogen
  • Both active smokers and non-smokers did not differ in the levels of their Lp-PLA2 activity

Findings: Subjects with MS in comparison to Subjects without MS (hsCRP)

  • Had a significantly higher levels of both Lp-PLA2 and hsCRP
  • hsCRP was 4.1 ± 3.3 mg/L versus 2.2 ± 3.2 mg/dL
  • Lp-PLA2 was 198 ± 45 nmol/mL/min versus 180 ± 48 nmol/mL/min
  • The levels of these markers increased as the number of components of metabolic syndrome increased
Acevedo et al. Comparison of Lipoprotein-Associated Phospholipase A2 and High Sensitive C-Reactive Protein as Determinants of Metabolic Syndrome in Subjects without Coronary Heart Disease: In Search of the Best Predictor. International Journal of Endocrinology.Volume 2015 (2015), Article ID 934681, 7 pages

Leave a Reply

Get DrBond

Stop Procrastinating. Start Bonding! Get the App on your phone to bond with the medical world, while on the go!
Apps StorePlay Store
What do you need help with?